PortfoliosLab logoPortfoliosLab logo
AVAH vs. TRVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AVAH vs. TRVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aveanna Healthcare Holdings Inc. (AVAH) and Trevi Therapeutics, Inc. (TRVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AVAH achieves a -13.22% return, which is significantly lower than TRVI's 13.50% return.


AVAH

1D
1.29%
1M
4.73%
YTD
-13.22%
6M
-21.40%
1Y
39.57%
3Y*
72.97%
5Y*
-10.99%
10Y*

TRVI

1D
5.57%
1M
-6.94%
YTD
13.50%
6M
11.28%
1Y
130.31%
3Y*
75.70%
5Y*
44.83%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

AVAH vs. TRVI - Yearly Performance Comparison


2026 (YTD)20252024202320222021
AVAH
Aveanna Healthcare Holdings Inc.
-13.22%78.77%70.52%243.59%-89.46%-38.33%
TRVI
Trevi Therapeutics, Inc.
13.50%203.88%207.46%-30.57%146.74%-67.13%

Correlation

The correlation between AVAH and TRVI is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Apr 28, 2021

0.16

Fundamentals

EPS

AVAH:

$1.20

TRVI:

-$0.43

Total Revenue (TTM)

AVAH:

$2.52B

TRVI:

$0.00

Gross Profit (TTM)

AVAH:

$823.98M

TRVI:

-$31.00K

EBITDA (TTM)

AVAH:

$306.37M

TRVI:

-$49.16M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AVAH vs. TRVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVAH
AVAH Risk / Return Rank: 6565
Overall Rank
AVAH Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
AVAH Sortino Ratio Rank: 7070
Sortino Ratio Rank
AVAH Omega Ratio Rank: 6868
Omega Ratio Rank
AVAH Calmar Ratio Rank: 6464
Calmar Ratio Rank
AVAH Martin Ratio Rank: 6161
Martin Ratio Rank

TRVI
TRVI Risk / Return Rank: 8989
Overall Rank
TRVI Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
TRVI Sortino Ratio Rank: 8787
Sortino Ratio Rank
TRVI Omega Ratio Rank: 8686
Omega Ratio Rank
TRVI Calmar Ratio Rank: 9191
Calmar Ratio Rank
TRVI Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVAH vs. TRVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aveanna Healthcare Holdings Inc. (AVAH) and Trevi Therapeutics, Inc. (TRVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AVAHTRVIDifference
Sharpe ratioReturn per unit of total volatility

-1.59

Sortino ratioReturn per unit of downside risk

-1.09

Omega ratioGain probability vs. loss probability

1.20

1.35

-0.15

Calmar ratioReturn relative to maximum drawdown

1.01

4.44

-3.44

Martin ratioReturn relative to average drawdown

1.81

10.40

-8.59

AVAH vs. TRVI - Sharpe Ratio Comparison

The current AVAH Sharpe Ratio is 0.58, which is lower than the TRVI Sharpe Ratio of 2.17. The chart below compares the historical Sharpe Ratios of AVAH and TRVI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AVAH vs. TRVI - Drawdown Comparison

The maximum AVAH drawdown since its inception was -94.76%, roughly equal to the maximum TRVI drawdown of -95.45%. Use the drawdown chart below to compare losses from any high point for AVAH and TRVI.


Loading charts...

Drawdown Indicators


AVAHTRVIDifference

Max Drawdown

Largest peak-to-trough decline

-94.76%

-95.45%

+0.69%

Max Drawdown (1Y)

Largest decline over 1 year

-39.44%

-29.50%

-9.94%

Max Drawdown (3Y)

Largest decline over 3 years

-41.40%

-61.96%

+20.56%

Max Drawdown (5Y)

Largest decline over 5 years

-94.76%

-80.26%

-14.50%

Current Drawdown

Current decline from peak

-45.00%

-7.73%

-37.27%

Average Drawdown

Average peak-to-trough decline

-63.57%

-61.49%

-2.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.95%

12.58%

+9.37%

Volatility

AVAH vs. TRVI - Volatility Comparison

Aveanna Healthcare Holdings Inc. (AVAH) has a higher volatility of 15.70% compared to Trevi Therapeutics, Inc. (TRVI) at 13.78%. This indicates that AVAH's price experiences larger fluctuations and is considered to be riskier than TRVI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AVAHTRVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.70%

13.78%

+1.92%

Volatility (6M)

Calculated over the trailing 6-month period

32.16%

39.38%

-7.22%

Volatility (1Y)

Calculated over the trailing 1-year period

68.16%

60.39%

+7.77%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

78.16%

88.26%

-10.10%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.42%

99.35%

-21.93%

Dividends

AVAH vs. TRVI - Dividend Comparison

Neither AVAH nor TRVI has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

AVAH vs. TRVI - Financials Comparison

This section allows you to compare key financial metrics between Aveanna Healthcare Holdings Inc. and Trevi Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M600.00M700.00M20222023202420252026
647.92M
0
(AVAH) Total Revenue
(TRVI) Total Revenue
Values in USD except per share items

Frequently Asked Questions


AVAH and TRVI have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AVAH has higher volatility (15.70%) compared to TRVI (13.78%). In terms of maximum drawdown, AVAH dropped -94.76% vs TRVI's -95.45%.

TRVI currently has the higher Sharpe Ratio (2.17 vs 0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AVAH and TRVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer